Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart home monitoring system get you out of the hospital faster after gut surgery?

NCT ID NCT07186738

Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a telemonitoring platform called EPOCA for patients who have had colorectal or bariatric surgery. The platform uses connected devices and a care team to monitor patients at home, aiming to allow earlier hospital discharge without increasing readmissions. Researchers will enroll 250 adults at Nantes University Hospital and track how many days they spend back in the hospital within 90 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EPOCA telemonitoring platform (device and care coordination service)
What this could lead to
If successful, this could show that remote monitoring safely allows earlier hospital discharge after digestive surgery, reducing costs and improving patient comfort.
What could go wrong
This is a small, single-center feasibility study, not a large trial. The platform may not reduce readmissions or complications, and results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The project concerns patients undergoing colorectal or bariatric surgery, either emergent or elective, in the digestive surgery department of Nantes University Hospital, who are at high risk of readmission

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female patients over 18 years of age. * Patients undergoing colorectal or bariatric surgery not routinely managed as outpatient procedures at Nantes University Hospital. * At least one of the following criteria: * Anticipated early discharge (within 24 hours post-surgery) for procedures not routinely managed as outpatient at the hospital. * Estimated risk of readmission greater than 6% according to the Tevis et al. nomogram, adapted to the postoperative context in digestive surgery (\>50 points on this score). * Patients enrolled in a health insurance plan Exclusion Criteria: * Discharge to a rehabilitation center requested by the patient * Condition routinely managed as an outpatient procedure * Patient under home hospitalization care * Suicidal or heteroaggressive risk in a patient living alone at home * Homeless patients * Pregnant or breastfeeding women * Patients under legal guardianship, conservatorship, or judicial protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Telemonitoring are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Telemonitoring

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Nantes

    NOT_YET_RECRUITING

    Nantes, Nantes, 44000, France

  • CHU Nantes- Digestive Surgery Department

    RECRUITING

    Nantes, Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.